It is our pleasure to welcome you onto our website to present CleveXel Pharma, its activities and collaboration opportunities to provide innovative solutions to meet unmet patient needs.
Created in 2013 as a spinoff from Cephalon Inc. (TEVA group), CleveXel Pharma is a pharmaceutical company specializing in innovative treatments.
Thanks to our unique expertise in drug development, we have strong assets to bring these molecules with high potential to clinical proof of concept, a critical stage of the value chain. Our partnership policy and our ability to identify molecules of therapeutic potential at an early stage are another strength of our model. CleveXel has a portfolio of 4 projects.
We hope our website will provide you with quality information about our activity and we will be happy to explore them with you. Don’t hesitate to contact us for collaboration opportunities!
CleveXel Pharma received the “Entreprise Innovante des Pôles” label by Medicen in 2015 and 2019.